OTCPK:UEEC

Stock Analysis Report

Executive Summary

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States.

Snowflake

Poor track record with worrying balance sheet.


Similar Companies

Bristol-Myers Squibb

NYSE:BMY

Share Price & News

How has United Health Products's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: UEEC's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

11.1%

UEEC

2.4%

US Medical Equipment

0.9%

US Market


1 Year Return

109.7%

UEEC

23.9%

US Medical Equipment

16.8%

US Market

Return vs Industry: UEEC exceeded the US Medical Equipment industry which returned 23.9% over the past year.

Return vs Market: UEEC exceeded the US Market which returned 16.8% over the past year.


Shareholder returns

UEECIndustryMarket
7 Day11.1%2.4%0.9%
30 Day4.0%3.6%4.5%
90 Day-39.3%2.2%6.2%
1 Year109.7%109.7%25.0%23.9%19.4%16.8%
3 Year1450.6%1450.6%90.3%84.5%47.5%38.0%
5 Year1174.5%1174.5%117.4%93.9%62.0%44.1%

Price Volatility Vs. Market

How volatile is United Health Products's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is United Health Products undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether United Health Products is trading at an attractive price based on the cash flow it is expected to produce in the future. But as United Health Products has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of UEEC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through United Health Products regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is United Health Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

23.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as United Health Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of UEEC’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access United Health Products's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has United Health Products performed over the past 5 years?

-25.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: UEEC has high quality earnings.

Growing Profit Margin: UEEC is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: UEEC is unprofitable, and losses have increased over the past 5 years at a rate of -25% per year.

Accelerating Growth: Unable to compare UEEC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: UEEC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (28.3%).


Return on Equity

High ROE: UEEC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is United Health Products's financial position?


Financial Position Analysis

Short Term Liabilities: UEEC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: UEEC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: UEEC is debt free.

Reducing Debt: UEEC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: UEEC has a high level of physical assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if UEEC's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: UEEC has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: UEEC has less than a year of cash runway if free cash flow continues to reduce at historical rates of -45.8% each year


Next Steps

Dividend

What is United Health Products's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.4%markettop25%3.7%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate UEEC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate UEEC's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if UEEC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if UEEC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of UEEC's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of United Health Products's salary, the management and board of directors tenure and is there insider trading?

3.2yrs

Average management tenure


CEO

Doug Beplate (64yo)

5yrs

Tenure

US$180,000

Compensation

Mr. Douglas K. Beplate, also known as Doug, had been the Chief Operating Officer of United Health Products, Inc. from November, 2013 until July, 2018 and has been its Chief Executive Officer and President  ...


CEO Compensation Analysis

Compensation vs Market: Doug's total compensation ($USD0.00) is below average for companies of similar size in the US market ($USD1.14M).

Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.


Management Age and Tenure

3.2yrs

Average Tenure

64yo

Average Age

Experienced Management: UEEC's management team is considered experienced (3.2 years average tenure).


Board Age and Tenure

1.7yrs

Average Tenure

Experienced Board: UEEC's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellUS$14,00013 Nov 19
Nathaniel Knight
EntityIndividual
Role
Member of the Board of Directors
CFO, Secretary
Shares20,000
Max PriceUS$0.70

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.


Management Team

  • Doug Beplate (64yo)

    President & CEO

    • Tenure: 5yrs
    • Compensation: US$180.00k
  • Nate Knight (70yo)

    CFO, Secretary

    • Tenure: 6.9yrs
  • Gerry Abate

    Chief Medical Director & Member of Medical Advisory Board

    • Tenure: 1.7yrs
  • Louis Schiliro (48yo)

    Chief Operating Officer

    • Tenure: 1.3yrs

Board Members

  • Clay Robinson

    Member of Medical Advisory Board

    • Tenure: 0yrs
  • Nate Knight (70yo)

    CFO, Secretary

    • Tenure: 6.9yrs
  • David Ramey

    Member of Medical Advisory Board

    • Tenure: 1.7yrs
  • Robert Denser (48yo)

    Director

    • Tenure: 5yrs
  • Richard Massoth

    Member of Medical Advisory Board

    • Tenure: 1.7yrs
  • Michael Jessen

    Member of Medical Advisory Board

    • Tenure: 1.7yrs
  • Gerry Abate

    Chief Medical Director & Member of Medical Advisory Board

    • Tenure: 1.7yrs
  • Lawrence Wolff

    Member of Medical Advisory Board

    • Tenure: 0yrs

Company Information

United Health Products, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: United Health Products, Inc.
  • Ticker: UEEC
  • Exchange: OTCPK
  • Founded: 1997
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$229.566m
  • Shares outstanding: 176.59m
  • Website: https://www.unitedhealthproductsinc.com

Number of Employees


Location

  • United Health Products, Inc.
  • 10624 South Eastern Avenue
  • Suite A209
  • Henderson
  • Nevada
  • 89052
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
UEECOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2007

Biography

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze produ ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/21 00:08
End of Day Share Price2019/11/20 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.